Showing 6-10 of 60 :
OM1 Launches Three New Products Powered by Patented AI Platform to Expedite Delivery of Personalized Medicine

The company is introducing OM1 Orion, OM1 Lyra, and OM1 Polaris, aligning AI technology and real-world data to offer unprecedented insights into the patient journey and further patient outcomes through prediction, precision, and discovery Business Wire May 06, 2024 09:00 AM Eastern Daylight Time Read the full press release >> BOSTON–(BUSINESS WIRE)–OM1 introduces three new products: OM1[…]

Lean Digital: How AI Drives Treatment Recommendations for Weight Loss

April 30, 2024 Healthcare IT Today Read the full article >> The first article in this series laid out what we know about body weight and obesity today. The rest of the Lean Digital series will look at some contributions that digital technologies are making toward solutions. The best contribution that information can make to weight management is to[…]

Joseph Zabinski Advocates for Patient Trust in AI Adoption in Dermatology Care

April 18, 2024 Managed Healthcare Executive Read the full article >> Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI at OM1, talked with MHE editors about the importance of patient acceptance in the adoption of AI in healthcare, emphasizing the need for trust and transparency in AI tools. Zabinksi highlighted the[…]

Dr Joseph Zabinski Discusses Using Artificial Intelligence to Identify Patients With GPP

AJMC April 4, 2024 Read the full article and watch the video >> It is important that physicians raise awareness around the condition of generalized pustular psoriasis (GPP) in order to close the current diagnostic gap, says Joseph Zabinski, PhD, MEM, managing director of artificial intelligence (AI) and personalized medicine at OM1. Transcript How is[…]

How is Artificial Intelligence Growing Up?

Dermatology Times March 10, 2024 Kaitlyn Bader Read the full article >> At the 2024 American Academy of Dermatology Annual Meeting in San Diego, California, Joseph Zabinski, PhD, MEM, the managing director of artificial intelligence (AI) and personalized medicine at OM1, a real-world data, AI, and technology company with a focus on chronic diseases, sat down with Dermatology[…]